Daiichi Sankyo Company Description
Daiichi Sankyo is the product of a spurt of merger mania in the Japanese drug business. After Sankyo purchased rival Daiichi Pharmaceutical for more than $7 billion in 2005, the two companies merged their operations into the newly formed Daiichi Sankyo, creating a top pharmaceutical manufacturer in Japan. Daiichi Sankyo manufactures prescription drugs, including treatments for cardiovascular, bone and joint, and infectious diseases. Its products are sold through medical representatives located worldwide. The company also makes over-the-counter (OTC) and generic drugs, as well as veterinary products and assorted chemicals.
View the Comprehensive Company Description for Daiichi Sankyo
The Company Description provides a historical perspective of Daiichi Sankyo's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Daiichi Sankyo's evolution in the marketplace.
